Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-36.47	93.24	146.77
Graham Fair Price	137.61	21.71	9.14
PEG	-99.49	0.35	-69.61
Price/Book	-21.57	6.83	8.70
Price/Cash Flow	90.81	-197.99	103.76
Prices/Earnings	-76.80	124.22	535.50
Price/Sales	5.08	22.25	21.17
Price/FCF	90.81	-197.99	103.76
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	24.07	0.48	0.39
Operating Margin	120.89	0.18	0.08
ROA	302.11	< 0.005	< 0.005
ROE	< 0.005	0.01	238.09
ROIC	< 0.005	0.01	191.49
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	< 0.005	-114.25
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.55	1.13	106.66
EPS QOQ	-0.08	3.50	4450.00
FCF QOQ	17.67	-1.53	-91.34
Revenue QOQ	0.05	-0.04	-26.32
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	179.88	218.45	21.44
Days Sales Outstanding (DSO)	45.08	53.99	19.76
Inventory Turnover	0.50	0.41	-17.66
Debt/Capitalization	0.72	0.66	-8.36
Quick Ratio	0.62	1.16	88.40
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	30.22	39.05	29.23
Cash	5.76	16.12	179.76
Capex	-1.84	-1.88	-2.07
Free Cash Flow	2.53	-1.35	-46.89
Revenue	12.42	11.98	-3.55
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.47	2.02	37.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	31.58	17.11	-45.83
Naive Interpretation	Member

06 - Financial Health · Bad

Rating